Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long- Term opioid therapy for pain

Annals of Internal Medicine

Volumn 165, Issue 4, 2016, Pages 245-252

  Coffin, Phillip O ^a   Behar, Emily ^a   Rowe, Christopher ^a   Santos, Glenn Milo ^a   Coffa, Diana ^b   Bald, Matthew ^c   Vittinghoff, Eric ^d  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NALOXONE; OPIATE; OXYCODONE; PETHIDINE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADULT; ANALGESIA; ARTICLE; CALIFORNIA; CHRONIC PAIN; EMERGENCY WARD; FEASIBILITY STUDY; FEMALE; GROWTH; HUMAN; INTERVENTION STUDY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SAFETY NET HOSPITAL; SCALE UP; CLINICAL TRIAL; DRUG OVERDOSE; HOSPITAL EMERGENCY SERVICE; MULTICENTER STUDY; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA;

ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; DRUG OVERDOSE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PRIMARY HEALTH CARE; SAN FRANCISCO;

EID: 84982082434     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2771     Document Type: Article

References (22)

1. Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS data brief, no 166. Hyattsville, MD: National Center for Health Statistics; 2014.
2. Khalid L, Liebschutz JM, Xuan Z, Dossabhoy S, Kim Y, Crooks D, et al. Adherence to prescription opioid monitoring guidelines among residents and attending physicians in the primary care setting. Pain Med. 2015;16:480-7. [PMID: 25529863] doi:10.1111/pme.12602.
3. Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, et al; Centers for Disease Control and Prevention (CDC). Increases in heroin overdose deaths - 28 States, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014;63:849-54. [PMID: 25275328].
4. Jones CM, Logan J, Gladden RM, Bohm MK. Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015;64:719-25. [PMID: 26158353].
5. Wheeler E, Jones TS, Gilbert MK, Davidson PJ; Centers for Disease Control and Prevention (CDC). Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:631-5. [PMID: 26086633].
6. Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:174. [PMID: 23372174] doi:10.1136/bmj.f174.
7. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. J Addict Dis. 2006;25:89-96. [PMID: 16956873].
8. Paone D, Heller D, Olson C, Kerker B. Illicit drug use in New York City. NYC Vital Signs. New York NY: Department of Mental Health and Hygeine; 2010:1-4.
9. National Services Scotland. National Naloxone Programme Scotland-naloxone kits issued in 2013/14 and trends in opioidrelated deaths. Glasgow, United Kingdom: National Services Scotland; 2014.
10. Giglio RE, Guohua L, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: A metaanalysis. Injury Epidemiology. 2015;2:1-9.
11. Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013; 158:1-9. [PMID: 23277895] doi:10.7326/0003-4819-158-1-201301010-00003.
12. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities. J Urban Health. 2015;92:758-72 [PMID: 26077643] doi:10.1007/s11524-015-9967-y.
13. Albert S, Brason FW 2nd, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12 Suppl 2:77-85. [PMID: 21668761] doi:10.1111/j.1526-4637.2011.01128.x.
14. Food and Drug Administration, Center for Drug Evaluation and Research, Office of the Assistant Secretary for Health, National Institutes of Drug Abuse, Centers for Disease Control and Prevention. Role of naloxone in opioid overdose fatality prevention, 2012. Accessed at www.fda.gov/downloads/Drugs/NewsEvents/UCM304621.pdf on 4 November 2015.
15. Bartoszek M, Algeo D, Sellars J. Operation OpioidSAFE. Fort Bragg, NC: Womack Army Medical Center; 2012.
16. Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. J Urban Health. 2005;82:303-11. [PMID: 15872192].
17. Naloxone (Narcan) nasal spray for opioid overdose. Med Lett Drugs Ther. 2016;58:1-2. [PMID: 26714239].
18. Substance Abuse and Mental Health Services Administration: Office of Applied Studies. Drug Abuse Warning Network Emergency Department Reference Guide, Version 5. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009:178.
19. Svendsen K, Borchgrevink P, Fredheim O, Hamunen K, Mellbye A, Dale O. Choosing the unit of measurement counts: The use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med. 2011;25:725-32. [PMID: 21378066] doi:10.1177/0269216311398300.
20. Von Korff, M, Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, et al. De facto long- Term opioid therapy for noncancer pain. Clin J Pain. 2008;24:521-7. [PMID: 18574361] doi:10.1097/AJP.0b013e318169d03b.
21. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain-United States, 2016. JAMA. 2016;315: 1624-45. [PMID: 26977696] doi:10.1001/jama.2016.1464.
22. Hirsch A, Proescholdbell SK, Bronson W, Dasgupta N. Prescription histories and dose strengths associated with overdose deaths. Pain Med. 2014;15:1187-95. [PMID: 25202775].